Cancer Bio-markers


<p style="&quot;text-align:" justify;"="">A biomarker may be used to see how well the body responds to a treatment for a disease or condition. A use of biomarkers in cancer research is developing drug targets and Surrogate endpoints.While numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers have already been used at some point in patient care; including, Liver Cancer, Chronic Myeloid Leukemia BRCA1 / BRCA2 (Breast/Ovarian Cancer), Melanoma/Colorectal Cancer, Ovarian Cancer Pancreatic Cancer

Types of cancer biomarkers

  • Breast
  • Colorectal
  • Leukemia/Lymphoma
  • Gastric
  • Lung
  • Melanoma
  • Pancreas

In cancer research, biomarkers are used in three primary ways

  • To help diagnose conditions, as in the case of identifying early stage cancers (Diagnostic)
  • To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment.
  • To predict how well a patient will respond to treatment.

    Related Conference of Cancer Bio-markers

    April 22-23, 2019

    Global Summit on Radiation Therapy & Targeted Tumors

    Vancouver, Canada
    June 12-13, 2019

    22nd Canada Meetings on Radiology & Novel Cancer Therapies

    Montreal, Quebec, Canada

    Cancer Bio-markers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in